ENTITY
Shanghai Haohai Biological Technology

Shanghai Haohai Biological Technology (6826 HK)

136
Analysis
Health Care • China
Shanghai Haohai Biological Technology engages in the research, development, manufacture, and sale of biomedical materials and pharmaceutical products. The company focuses on therapeutic areas including ophthalmology, medical aesthetics and wound care, orthopedics, and anti-adhesion and hemostasis, with key products such as intraocular lenses, hyaluronic acid dermal fillers, and sodium hyaluronate injections. It is headquartered in Shanghai, China, and was founded in 2007.
more
bearish•ADICON
•14 Apr 2023 09:30

Adicon Holdings Pre-IPO - Thoughts on Valuation

ADICON Holdings Limited (ADI HK)  is looking to raise about US$400m in its upcoming HK IPO. In this note, we talk about our thoughts on valuation.

Logo
715 Views
Share
•09 Apr 2023 10:05

A-H Premium Weekly (Apr 7th): China Vanke, China Rail Group, Huatai Securities, Yankuang Energy

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Vanke, China Rail Group, Huatai Securities, Yankuang...

Logo
541 Views
Share
•26 Mar 2023 10:30

A-H Premium Weekly (Mar 24th): Dongfang Electric, CEEC, Great Wall Motor

We analyzed WoW changes in A-H premium and highlight changes in A-H premium for Dongfang Electric, CEEC, Great Wall Motor.

Logo
420 Views
Share
•20 Mar 2023 08:05

A-H Premium Weekly (Mar 17th): China Telecom, China Shenhua, Great Wall Motor, CEEC

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Telecom, China Shenhua, Great Wall Motor, CEEC.

Logo
415 Views
Share
•12 Mar 2023 10:30

A-H Premium Weekly (Mar 10th): China Shenhua, PetroChina, China Southern, ZTE, CRRC, CICC

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Shenhua, PetroChina, China Southern, ZTE, CRRC, CICC.

Logo
518 Views
Share
x